Esophageal pH Monitoring
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage and coding for esophageal pH monitoring (wireless and catheter-based) and catheter-based impedance-pH monitoring for Blue Cross Blue Shield - Rhode Island members, including Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medically Necessary Indications
Covered when ALL of the following are met
Supports both Medicare Advantage and Commercial Products
Pediatric exception for catheter-based monitoring
Not Covered / Not Medically Necessary Indications
Explicit not-covered / not medically necessary statement
This policy addresses coverage for catheter-based 24-hour impedance-pH monitoring as part of esophageal pH testing. CPT codes 91037 and 91038 (catheter intraluminal impedance monitoring) are not covered for Medicare Advantage Plans and not medically necessary for Commercial Products. The payer considers standard catheter-based or wireless pH monitoring using CPT codes 91034 and 91035 medically necessary when submitted with an appropriate covered ICD-10 diagnosis code, but impedance-pH procedures (91037/91038) are explicitly excluded based on insufficient evidence of improved health outcomes for defining refractory GERD on PPI therapy.
Specifically, the use of 24-hour catheter-based impedance-pH monitoring to evaluate individuals with established GERD who remain symptomatic despite twice-daily PPI therapy is considered not covered for Medicare Advantage and not medically necessary for Commercial Products. This restriction applies when the test is used to define refractory GERD in patients on PPI treatment because the evidence was judged insufficient to demonstrate clinical benefit.
Coding and Billing
| 91037 | Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation |
| 91038 | Esophageal function test, gastroesophageal reflux test with nasal catheter intraluminal impedance electrode(s) placement, recording, analysis and interpretation; prolonged (greater than 1 hour, up to 24 hours) |
Provider Actions and Billing Guidance
Prior authorization not required but diagnosis linkage mandatory
CPT codes 91034 and 91035 require an appropriate covered ICD-10 diagnosis code from the payer's provided list to be considered medically necessary; prior authorization is not applicable for these codes.
- Prior authorization: Not applicable (see policy PRIOR AUTHORIZATION).
- Diagnosis linkage: Must be filed with one of the ICD-10 CM Diagnosis Codes listed in the payer's Covered Diagnosis Codes spreadsheet.
Policy does not guarantee payment — verify authorization/coverage
This policy is informational and does not guarantee payment; prior authorization or coverage verification may still be required per the member's benefit documents and participation agreements.
- Providers should confirm any prior authorization requirements specific to the member's plan or contract.
- Participation agreements and subscriber/employer documents supersede this policy.
Check member Evidence of Coverage / Subscriber Agreement
Benefits and coverage may vary by contract; providers must consult the member's Evidence of Coverage or Subscriber Agreement for applicable benefits and not medically necessary determinations.
- For member-specific benefits and eligibility, call the provider call center as directed in the policy.
Confirm plan-specific billing and documentation requirements
Providers should follow payer guidance for billing and documentation specific to esophageal pH monitoring; verify plan-specific rules before delivering services.
- Confirm covered CPT codes and required diagnosis linkage prior to claim submission.
- Contact the provider call center for member-specific questions.
Verify member benefits and eligibility via provider call center
For member-specific benefits and eligibility, providers must verify coverage via the provider call center; subscriber agreements and employer agreements supersede this medical policy.
- Benefits may vary between groups and contracts; do not rely on the policy alone to determine coverage.
Risk of member liability if service deemed non-covered or not medically necessary
If services are determined to be not medically necessary (or are medically necessary but non-covered benefits), the provider may be unable to charge the member unless the member was informed and agreed in writing in advance.
- Obtain prior written member agreement before providing services expected to be non-covered to avoid denial and member billing disputes.
- Refer to participation agreement(s) for applicable provisions.
Background
Esophageal pH monitoring records esophageal acid exposure over a monitoring period and can help diagnose gastroesophageal reflux disease when history and endoscopy are inconclusive. A nasally introduced catheter with a pH electrode typically records pH over a 24-hour period, while a mucosal-attached wireless pH capsule can record for up to 96 hours. Impedance-pH monitoring combines pH measurement with intraluminal impedance to detect liquid or gas reflux events of any pH and determine flow direction, but catheter-based impedance testing (CPTs 91037/91038) is not covered or is considered not medically necessary under this policy for the indications described.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.